GPT and obesity disorder: We examined changes in the blood levels of creatinine (to assess kidney function), ALT (indicating liver function), and total cholesterol (as an obesity factor), and no changes in blood creatinine levels after the administration of ATS or SOH were observed, suggesting no kidney toxicity.